Interview: Prof. Robert Riener – Head of the Department of Health Sciences & Technology, ETH Zurich, Switzerland

25.07.2016
Robert Riener, University of BaselProfessor Dr. Robert Riener speaks about the much anticipated Cybathlon event and its importance to technology transfer, the Swiss education system’s ability to attract international talent, and his goals for the future. You have been leading the Department of Health Sciences and Technology at ETH Zurich since February 2016. Could you start by introducing yourself and the Department of Health Sciences and Technology to our readers?
We have on average 25 spinoff companies per year, and these companies have very high life expectancies.
Become a PharmaBoardroom Member for free to access this content
Join the 35,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In
Tags:
R&D, Research, Development, Education, Switzerland, Pharma, International, free, Interview, Insight

Related Interviews

Access / Medicines Patent Pool Head on Mutual Benefits of Voluntary Licensing of Medicines in LMICs

The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to, and facilitate the development of, life-saving medicines for low- and middle-income countries. Executive…

Bruno Delie – General Manager, Luye Pharma Switzerland

Luye Pharma is a China-headquartered fully integrated oncology and CNS specialist. Bruno Delie, general manager for Switzerland, discusses the organization’s ambitious European expansion plan, looking to establish affiliates in the…

Karin Blumer – Director Global Patient Engagement, Novartis Oncology

Karin Blumer, director of global patient engagement at Swiss giant Novartis, gives fascinating insights into the global patient advocacy landscape today and how Novartis interacts with it, the work being…

Latest Report

Related Articles

India / A Renewed Global Role Based on Innovation, Self-Reliance & Quality

The Indian pharma industry has demonstrated spectacular growth based on its strength as a global generics manufacturer. Yet Indian pharma is not merely resting on its laurels. After shining through…

India / Pharma Betting on Innovation Over Next 25 Years, say OPPI Summit Speakers

India’s pharma industry has big dreams. At the recent Annual Summit of Organisation of Pharmaceutical Producers of India (OPPI) the nation’s policymakers, academicians, industry leaders, innovators, and scientists gathered to…

USA / New NIH Director Bertagnolli to Focus on Access

Nominated by President Joe Biden, the National Institutes of Health’s (NIH) new director Monica M. Bertagnolli took the reins of the world’s largest public funder of biomedical research earlier this…

Related Content

R&D
Research
Development
Education
Switzerland
Pharma
International